. 2023 Oct 31;25(4):770–777. doi: 10.1080/26895269.2023.2271903

Table 3.

Hormonal test results of trans men prescribed testosterone for gender affirming hormone treatment (GAHT) and cisgender men prescribed testosterone for testosterone deficiency (TD), N = 432.

Test	GAHT, median (IQR)	TD, median (IQR)	p value
Serum testosterone levels (nmol/L)	16.0 (11.3–20.4)	14.8 (9.6–19.6)	0.132^a
Serum follicle stimulating hormone levels (IU/L)	5.0 (2.1–8.0)	4.9 (2.0–12.0)	0.737^a
Serum luteinizing hormone levels (IU/L)	4.0 (1.1–6.0)	2.1 (1.0–5.3)	0.206^a

^{^a}

Wilcoxon rank sum test was used.